Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
China-based biopharma. Mazdutide (dual GCG/GLP-1) approved by China NMPA June 2025 for chronic weight management; first dual GCG/GLP-1 agonist globally. Partnership with Eli Lilly.
Browse all official SEC filings including annual reports, quarterly updates, and material event disclosures.
Showing 1 of 1 filings